BI-1206

CAT: 0931-T9901A-951-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0931-T9901A-951-01Size:1 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Target
Immunology/Inflammation related|||Others
Related Pathways
Immunology/Inflammation|||Others
Bioactivity
BI-1206 is a recombinant antagonistic human monoclonal antibody targeting Fc?RIIB (CD32B) . It inhibits CD20 internalization induced by Rituximab, whether used alone or in combination with drugs such as Ibrutinib, Venetoclax, and CHOP. BI-1206 can enhance or restore the activity of Rituximab or other anti-CD20 monoclonal antibodies and demonstrates cytolytic activity against malignant B cells. BI-1206 is applicable in research on cancers such as mantle cell lymphoma (MCL) .
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Popular Products